FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Compounder Says Lilly, Novo Nordisk Violate Antitrust

Strive Specialties, a compounding pharmacy, says in a suit filed in a Texas federal court that Eli Lilly and Novo Nordisk are violating antitrust laws...

latest-news-card-1
Human Drugs

Inspection Flags Sanitation, Quality Control Lapses at Biocon

FDA cites Biocon Biologics for a series of manufacturing and quality control deficiencies following an inspection of the companys drug substance manuf...

latest-news-card-1
Human Drugs

8 Observations in Shilpa Medicare 483

FDA releases the form FDA-483 with eight observations from an inspection at Indias Shilpa Medicare drug manufacturing facility.

latest-news-card-1
Human Drugs

Chinese Firms Asked About Counterfeit GLP-1 Drugs

The ranking member of a House Select Committee on competition with China writes to three Chinese drug companies asking for detailed information on the...

Medical Devices

BD New Breast Biopsy System Cleared

FDA clears a BD 510(k) for its EnCor EnCompass Breast Biopsy and Tissue Removal System, a new platform designed to allow clinicians to perform breast ...

latest-news-card-1
Human Drugs

2 Voucher Program Drug Reviews Delayed: Reuters

Reuters reports exclusively that FDA medical reviewers have slowed reviews on two drugs in the new Commissioners National Priority Voucher Program due...

latest-news-card-1
Human Drugs

Jazz Unloads Priority Voucher for $200 Million

Jazz Pharmaceuticals sells its FDA Priority Review Voucher for $200 million to an undisclosed purchaser.

Medical Devices

Expanded Use Cleared for Robotic Cochlear Implant Insertion

FDA clears an iotaMotion 510(k) for an expanded pediatric indication for its iotaSOFT robotic-assisted cochlear implant insertion system.

latest-news-card-1
Human Drugs

Bumpus Named Chief Scientific Officer at Charles River Labs

Charles River Laboratories names former FDA principal deputy commissioner Namandj N. Bumpus as senior vice president and chief scientific and innovati...

latest-news-card-1
Human Drugs

FDA Hits Altor Bio Over Promo Violations

FDA sends an untitled letter to Altor BioScience, alleging that promotional Web pages for bladder cancer drug Anktiva are false or misleading and viol...